Synlett 2009(10): 1583-1586  
DOI: 10.1055/s-0029-1217326
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Efficient, High-Yield, One-Pot Protocol for the Synthesis of 1,2,4-Oxadiazine Derivatives

Orazio A. Attanasia, Livius Cotarcab, Gianfranco Favia, Paolino Filipponea, Francesca R. Perrullia, Stefania Santeusanio*a
a Istituto di Chimica Organica della Facoltà di Scienze e Tecnologie, Università degli Studi di Urbino ‘Carlo Bo’, Via I Maggetti 24, 61029 Urbino, Italy
Fax: +39(0722)303441; e-Mail: stefania.santeusanio@uniurb.it;
b ZaCh System S.p.A., Via Dovaro 2, 36045 Almisano di Lonigo (VI), Italy
Further Information

Publication History

Received 23 March 2009
Publication Date:
02 June 2009 (online)

Abstract

1,2-Diaza-1,3-dienes easily react as Michael acceptors with arylamidoximes in a one-pot, high-yield heterocyclization process. Depending on the linear or cyclic structure of the ene mojety, 1,2,4-oxadiazin-5-ones or spiro cycloalkyl-1,2,4-oxadiazin-5-one derivatives can be directly obtained.

    References and Notes

  • 1a Qian X, Bergnes G, and Morgans DJ. inventors; WO  2004091547. 
  • 1b Mezei J. Küttel S. Szemere L. Rácz I. Pharmazie  1984,  39:  397 
  • 1c Weller HN. Miller AV. Dickinson KEJ. Hedberg SA. Delaney CL. Serafino RP. Moreland S. Heterocycles  1993,  36:  1027 
  • 2a Berkowitz PT. Long RA. Dea P. Robins RK. Matthews TR. J. Med. Chem.  1977,  20:  134 
  • 2b Khan KM. Rahat S. Choudhary MI. . Ghani U. Perveen S. Khatoon S. Dar A. Malik A. Helv. Chim. Acta  2002,  85:  559 
  • 2c Arikan N. Sumengen D. Dulger B. Turk. J. Chem.  2008,  32:  147 
  • 3 Fylaktakidou KC. Hadjipavlou-Litina DJ. Litinas KE. Varella EA. Nicolaides DN. Curr. Pharm. Des.  2008,  1001 
  • 4a Clapp LB. In Advances in Heterocyclic Chemistry   Vol. 20:  Katritzky AR. Academic Press; New York: 1976.  p.65-116  
  • 4b Hébert N. Hannah AL. Sutton SC. Tetrahedron Lett.  1999,  40:  8547 
  • 4c Crestey F. Lebargi C. Lasne M.-C. Perrio C. Synthesis  2007,  3406 
  • 4d Du W. Truong Q. Qi H. Guo Y. Chobanian HR. Hagmann WK. Hale JJ. Tetrahedron Lett.  2007,  48:  2231 
  • 4e Braga AL. Lüdtke DS. Alberto EE. Dorneller L. Severo Filho WA. Corbellini VA. Rosa DM. Schwab RS. Synthesis  2004,  1589 
  • 4f Ispikoudi M. Litinas KE. Fylaktakidou KC. Heterocycles  2008,  75:  1321 
  • 4g Hamze A. Hernandez JF. Fulcrand P. Martinez J. J. Org: Chem.  2003,  68:  7316 
  • 4h Zhou T. Chen Z.-C. Synth. Commun.  2002,  32:  887 
  • 5a Durust Y. Altug C. Kilic F. Phosphorus, Sulfur Silicon Relat. Elem.  2007,  182:  299 
  • 5b Srivastava RM. De Morais LPF. De Melo Souto SC. Carpenter GB. De Carvalho LT. Tetrahedron Lett.  2006,  47:  3173 
  • 5c Hussein AQ. Heterocycles  1987,  26:  163 
  • 5d Tabei K. Kawashima E. Takada T. Kato T. Chem. Pharm.
    Bull.  1982,  30:  3987 
  • 5e Santilli AA. Scotese AC. J. Heterocycl. Chem.  1979,  16:  213 
  • 6a Attanasi OA. De Crescentini L. Filippone P. Mantellini F. Santeusanio S. ARKIVOC  2002,  (xi):  274 ; and references cited therein
  • 6b Attanasi OA. De Crescentini L. Favi G. Filippone P. Mantellini F. Santeusanio S. Synlett  2004,  549 
  • 6c Attanasi OA. Carvoli G. Filippone P. Perrulli FR. Santeusanio S. Serri AM. Synlett  2004,  1643 
  • 6d Attanasi OA. Baccolini G. Boga C. De Crescentini L. Filippone P. Mantellini F. J. Org. Chem.  2005,  70:  4033 
  • 6e Attanasi OA. De Crescentini L. Favi G. Filippone P. Lillini SP. Mantellini F. Santeusanio S. Synlett  2005,  1474 
  • 6f Palacios F. Aparicio D. López Y. de los Santos JM. Tetrahedron  2005,  61:  2815 
  • 6g Attanasi OA. Abbiati G. Rizzato S. Rossi E. Santeusanio S. Tetrahedron  2007,  63:  11055 
  • 6h Attanasi OA. Davoli P. Favi G. Filippone P. Forni A. Moscatelli G. Prati F. Org. Lett.  2007,  9:  3461 
  • 6i Attanasi OA. Favi G. Filippone P. Perrulli FR. Santeusanio S. Org. Lett.  2009,  11:  309 
  • 7 Attanasi OA. Favi G. Filippone P. Giorgi G. Lillini S. Mantellini F. Perrulli FR. Synlett  2006,  2731 
  • 11 Attanasi OA. De Crescentini L. Favi G. Filippone P. Golobič A. Lillini S. Mantellini F. Synlett  2006,  2735 
  • 14 Attanasi OA. Berretta S. De Crescentini L. Favi G. Filippone P. Giorgi G. Lillini S. Mantellini F. Tetrahedron Lett.  2007,  48:  2449 
  • 15 Farge D, Leboul J, Goff Y, and Poiget G. inventors; DE  2640464. 
8

One-Pot Procedure for the Preparation of 1,2-Diaza-1,3-butadiene Derivatives 4a-j 1,2-Diazabuta-1,3-diene 1a-f (1 mmol), prepared and used as a EE/EZ-isomer mixture, [6a] and arylamidoxime 2a-c (1 mmol) were dissolved in alcohol (8 mL) with magnetic stirring, and the reaction mixture was allowed to stand at r.t. until disappearance of the reagents and the formation of Michael adduct 3a-j (0.33-4.0 h, monitored by SiO2 TLC). A stoichiometric amount of NaH was added, and the crude reaction mixture was allowed to stand at r.t. until the complete disappearance of 3a-j was observed by TLC analysis (0.5-8.0 h). After removal of the solvent in vacuo, the residue was suspended in H2O, neutralized with 2 N HCl, extracted with CH2Cl2, and the organic extracts dried. After filtering, the organic solvent was evaporated, and the solid residue was crystallized from the appropriate solvent.

9

Data for Michael Adduct 3f
White powder from EtOAc-n-pentane, mp 99-100 ˚C (dec.). IR (KBr): 3490, 3395, 2995, 1765, 1730, 1700, 1640, 1590, 1545 cm. ¹H NMR (400 MHz, DMSO-d 6): δ = 1.91 (s, 3 H, CH3), 3.67 (s, 6 H, 2 × OCH3), 4.98 (s, 1 H, CH), 6.29 (s, 2 H, NH2), 7.36-7.43 (m, 3 H, Ar), 7.61 (d, J = 8.0 Hz, 2 H, Ar), 10.15 (s, 1 H, NH). ¹³C NMR (100 MHz DMSO-d 6): δ = 12.90, 51.86, 51.93, 84.33, 126.08, 128.20, 129.72, 132.07, 148.14, 152.82, 154.46, 169.25. MS: m/z (%) = 322 [M+] (0.6), 291 (0.5), 263 (1), 249 (1), 136 (15), 115 (58), 83 (100). Anal. Calcd for C14H17N3O5: C, 54.72; H, 5.58; N, 13.67. Found: C, 54.73; H, 5.61; N, 13.62.

10

Data for Methyl 2-[1-(5-Oxo-3-phenyl-5,6-dihydro-4 H -1,2,4-oxadiazin-6-yliden)ethyl]-1-hydrazinecarboxylate (4f)
Pink powder from CH2Cl2-PE (40-60 ˚C), mp 148-149 ˚C (dec.). IR (KBr): 3420, 3390, 3320, 2990, 1770, 1740, 1620, 1575 cm. ¹H NMR (400 MHz, DMSO-d 6): δ = 1.97 (s, 3 H, CH3), 3.61 (s, 3 H, OCH3), 6.88 (br s, 1 H, NH), 7.52-7.63 (m, 3 H, Ar), 7.98 (d, J = 6.8 Hz, 2 H, Ar), 9.93 (br s, 1 H, NH), 11.43 (br s, 1 H, NH). ¹³C NMR (100 MHz DMSO-d 6): δ = 12.12, 51.81, 93.61, 127.25, 128.30, 128.85, 132.48, 152.38, 154.36, 160.94, 181.72. ESI-MS: m/z calcd for C13H14N4O4: 290.1; found: 291 [M+1].

12

Typical One-Pot Procedure for the Synthesis of Spirocycloalkyl-1,2,4-oxadiazin-5-one Derivatives 5a-d
To a solution of arylamidoxime 2b,c (1 mmol) in EtOH (4 mL), 1-cycloalkenyl-1-diazene 1g-j (1 mmol), prepared as previously reported and dissolved in EtOH (4 mL), was added dropwise at r.t. with magnetic stirring. The reaction mixture was allowed to stand at r.t. until the disappearance of the reactants (0.5-6.0 h) and the formation of the pertinent 1,4-adduct 3. The crude reaction mixture was then treated with NaH (1 equiv) until complete disappearance of the intermediate was observed by TLC analysis (0.5-4.0 h). After removal of the solvent in vacuo, the residue was suspended in H2O, neutralized with 2 N HCl, extracted with CH2Cl2, and the organic extracts dried. After filtering, the organic solvent was evaporated and the solid residue was crystallized from the appropriate solvent.

13

Data for Methyl 2-{12-Oxo-9-phenyl-7-oxa-8,11-diazaspiro[5.6]dodec-8-en-1-yliden}-1-hydrazine-carboxylate (5b)
White powder from THF-n-pentane, mp 218-219 ˚C (dec.). IR (Nujol): 3368, 3187, 1749, 1713, 1616 cm. ¹H NMR (400 MHz, DMSO-d 6): δ = 1.34-1.40 (m, 1 H, cy), 1.66-1.99 (m, 5 H, cy), 2.19-2.27 (m, 1 H, cy), 2.90-2.94 (m, 1 H, cy), 3.62 (s, 3 H, OCH3), 7.44-7.51 (m, 3 H, Ar), 7.65 (d, J = 6.8 Hz, 2 H, Ar), 10.23 (s, 1 H, NH), 11.28 (s, 1 H, NH). ¹³C NMR (100 MHz, DMSO-d 6): δ = 19.83, 22.97, 24.75, 31.24, 51.87, 79.43, 127.19, 128.47, 129.44, 131.03, 150.26, 153.64, 154.41, 167.10. ESI-MS: m/z calcd for C16H18N4O4: 330.1; found: 331 [M + 1].